MedTrace Logo

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

NCT05746143 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-05-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Conditions

  • Spine Fusion
  • Lumbar Spine Degeneration
  • Pain, Postoperative
  • Lumbar Spine Spondylosis

Interventions

DRUG

Zolpidem Tartrate 10 mg

two days preoperatively and five days postoperatively

DRUG

Placebo

two days preoperatively and five days postoperatively

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2029-01-31
Completion
2030-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05746143 on ClinicalTrials.gov